Antibody response to pneumococcal capsular polysaccharide vaccine in Down syndrome patients

Brazilian Journal of Medical and Biological Research

Volumn 39, Issue 12, 2006, Pages 1587-1592

  Costa Carvalho, B T ^a,b   Martinez, R M A ^a   Dias, A T N ^c   Kubo, C A ^d   Barros Nunes, P ^a   Leiva, L ^d   Sole D ^a   Carneiro Sampaio, M M S ^d   Naspitz, C K ^a   Sorensen, R U ^d,e  

^a FEDERAL UNIVERSITY OF SÃO PAULO   (Brazil)

^b Universidade Federal do Ceará ^*  (Brazil)

^c FEDERAL UNIVERSITY OF CEARÁ   (Brazil)

^d UNIVERSITY OF SÃO PAULO   (Brazil)

^e LOUISIANA STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Down syndrome; IgG subclass; Immunoglobulin; Pneumococcal antibodies; Polysaccharide vaccine; Streptococcus pneumoniae

Indexed keywords

BACTERIUM ANTIBODY; IMMUNOGLOBULIN G; PNEUMOCOCCUS VACCINE;

ADOLESCENT; ANTIBODY PRODUCTION; ANTIBODY RESPONSE; ARTICLE; BLOOD ANALYSIS; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; DOWN SYNDROME; FEMALE; HUMAN; IMMUNIZATION; MALE; SEROTYPE; STREPTOCOCCUS INFECTION; STREPTOCOCCUS PNEUMONIAE; TREATMENT OUTCOME;

BACTERIA (MICROORGANISMS); STREPTOCOCCUS PNEUMONIAE;

EID: 33847634852     PISSN: 0100879X     EISSN: 1414431X     Source Type: Journal    
DOI: 10.1590/S0100-879X2006001200010     Document Type: Article

References (33)

1. Hassold TJ, Jacobs PA. Trisomy in man. Annu Rev Genet 1984; 18: 69-97.
2. Castilla EE, Orioli IM. ECLAMC: the Latin-American collaborative study of congenital malformations. Community Genet 2004; 7: 76-94.
3. Ugazio AG, Maccario R, Notarangelo LD, Burgio GR. Immunology of Down syndrome: a review. Am J Med Genet SuppI 1990; 7: 204-212.
4. Murphy M, Insoft RM, Pike-Nobile L, Epstein LB. A hypothesis to explain the immune defects in Down syndrome. Prog Clin Biol Res 1995; 393: 147-167.
5. Burgio GR, Ugazio AG, Nespoli L, Maccario R. Down syndrome: A model of immunodeficiency. Birth Defects 1983; 19: 325-327.
6. Lockitch G, Singh VK, Puterman ML, Godolphin WJ, Sheps S, Tingle AJ, et al. Age-related changes in humoral and cell-mediated immunity in Down syndrome children living at home. Pediatr Res 1987; 22: 536-540.
7. Loh RK, Harth SC, Thong YH, Ferrante A. Immunoglobulin G sub-class deficiency and predisposition to infection in Down's syndrome. Pediatr Infect Dis J 1990; 9: 547-551.
8. Gordon MC, Sinha SK, Carlson SD. Antibody responses to influenza vaccine in patients with Down's syndrome. Am J Ment Defic 1971; 75: 391-399.
9. Griffiths AW, Sylvester PE. Mongols and non-mongols compared in their response to active tetanus immunisation. J Ment Defic Res 1967; 11: 263-266.
10. Adinolfi M, Gardner B, Martin W. Observations on the levels of gamma G, gamma A, gamma M globulins, anti-A and anti-B agglutinins, and antibodies to Escherichia coli in Down's anomaly. J Clin Pathol 1967; 20: 860-864.
11. Lopez V, Ochs HD, Thuline HC, Davis SD, Wedgwood RJ. Defective antibody response to bacteriophage phichi 174 in Down syndrome. J Pediatr 1975; 86: 207-211.
12. Zielen S, Buhring I, Ewald F, Ahrens P, Hofmann D. Immunoglobulin subclasses and polysaccharide specific immuno-deficiency states in patients with recurrent respiratory infections. Pediatr Pulmonol Suppl 1997; 16: 146-147.
13. Nurmi T, Leinonen M, Haiva VM, Tiilikainen A, Kouvalainen K. Antibody response to pneumococcal vaccine in patients with trisomy-21 (Down's syndrome). Clin Exp Immunol 1982; 48: 485-490.
14. Sorensen RU, Hidalgo H, Moore C, Leiva LE. Post-immunization pneumococcal antibody titers and IgG subclasses. Pediatr Pulmonol 1996; 22: 167-173.
15. Sorensen RU, Leiva LE, Javier FC III, Sacerdote DM, Bradford N, Butler B, et al. Influence of age on the response to Streptococcus pneumoniae vaccine in patients with recurrent infections and normal immunoglobulin concentrations. J Allergy Clin immunol 1998; 102: 215-221.
16. Posfay-Barbe KM, Wald ER. Pneumococcal vaccines: do they prevent infection and how? Curr Opin Infect Dis 2004; 17: 177-184.
17. Chaushu S, Yefe NE, Becker A, Shapira J, Chaushu G. Parotid salivary immunoglobulins, recurrent respiratory tract infections and gingival health in institutionalized and non-institutionalized subjects with Down's syndrome. J Intellect Disabil Res 2003; 47: 101-107.
18. Anneren G, Magnusson CG, Lilja G, Nordvall SL. Abnormal serum IgG subclass pattern in children with Down's syndrome. Arch Dis Child 1992; 67: 628-631.
19. de Hingh YC, van der Vossen PW, Gemen EF, Mulder AB, Hop WC, Brus F, et al. Intrinsic abnormalities of lymphocyte counts in children with Down syndrome. J Pediatr 2005; 147: 744-747.
20. Barrett DJ, Ayoub EM. IgG2 subclass restriction of antibody to pneumococcal polysaccharides. Clin Exp Immunol 1986; 63: 127-134.
21. Shackelford PG, Granoff DM, Madassery JV, Scott MG, Nahm MH. Clinical and immunologic characteristics of healthy children with subnormal serum concentrations of IgG2. Pediatr Res 1990; 27: 16-21.
22. Costa Carvalho BT, Nagao AT, Arslanian C, Carneiro Sampaio MM, Naspitz CK, Sorensen RU, et al. Immunological evaluation of allergic respiratory children with recurrent sinusitis. Pediatr Allergy Immunol 2005; 16: 534-538.
23. Casal J, Tarrago D. Immunity to Streptococcus pneumoniae: Factors affecting production and efficacy. Curr Opin Infect Dis 2003; 16: 219-224.
24. Douglas RM, Paton JC, Duncan SJ, Hansman DJ. Antibody response to pneumococcal vaccination in children younger than five years of age. J Infect Dis 1963; 148: 131-137.
25. Paton JC, Toogood IR, Cockington RA, Hansman D. Antibody response to pneumococcal vaccine in children aged 5 to 15 years. Am J Dis Child 1986; 140: 135-138.
26. Balmer P, North J, Baxter D, Stanford E, Melegaro A, Kaczmarski EB, et al. Measurement and interpretation of pneumococcal IgG levels for clinical management. Clin Exp Immunol 2003; 133: 364-369.
27. Claesson BA, Lagergard T, Trollfors B. Development of serum anti-bodies of the immunoglobulin G class and subclasses against the capsular polysaccharide of Haemophilus influenzae type b in children and adults with invasive infections. J Clin Microbiol 1988; 26: 2549-2553.
28. IshigamiMiyake TT, Nagao AT, Arslanian C, Harima HA, Costa-Carvalho BT, Cameiro-Sampaio MM, et al. Evaluation of serum levels of IgG subclasses and anti-ribosyl-ribitolphosphate IgG and IgG2 in children with Haemophilus influenzae b meningitis. J Trop Pediatr 1999; 45: 130-134.
29. Dizon JG, Goldberg BJ, Kaplan MS. How to evaluate suspected immunodeficiency. Pediatr Ann 1998; 27: 743-750.
30. Brandileone MC, Vieira VS, Casagrande ST, Zanella RC, Guerra ML, Bokermann S, et al. Prevalence of serotypes and antimicrobial resistance of Streptococcus pneumoniae strains isolated from Brazilian children with invasive infections. Pneumococcal Study Group in Brazil for the SIREVA Project. Regional System for Vaccines in Latin America. Microb Drug Resist 1997; 3: 141-146.
31. Taunay AE, Austrian R, Landgraf IM, Vieira MF, Melles CE. Sero-types of Streptococcus pneumoniae isolated from cerebrospinal fluid in 1977-1988 in São Paulo city, Brazil. Rev Inst Med Trop São Paulo 1990; 32: 11-15.
32. Brandileone MC, de Andrade AL, Di Fabio JL, Guerra ML, Austrian R. Appropriateness of a pneumococcal conjugate vaccine in Brazil: potential impact of age and clinical diagnosis, with emphasis on meningitis. J Infect Dis 2003; 187: 1206-1212.
33. Advisory Committee on Immunization Practices (ACIP). Preventing pneumococcal disease among infants and young children. MMRW Recomm Rep 2000; 49: 1-38.